Our results confirm these previous observations on the role of IL-8 in resistance to EGFR inhibition and further expand them by demonstrating that upregulation of p38 MAPK signaling is responsible for enhanced IL-8 secretion in resistant tumor cells. This evidence concerns the gene EGFR and neoplasm.